Serentis secures £10m second tranche of series A financing
Adamant Ventures has joined existing investors in a £10m (€12.5m) second tranche of a series A round of funding for Cambridge-based biopharma group Serentis.
MVM
Adamant Ventures has joined existing investors in a £10m (€12.5m) second tranche of a series A round of funding for Cambridge-based biopharma group Serentis.
MVM